Site Search

Share

X

Search Results

Utilization Management in Breast Cancer and Hepatocellular Carcinoma

Executive Summary Utilization management (UM) refers to a variety of practices that health plans and pharmacy benefit managers employ to confirm the use of specific drugs or services aligns with the payer’s policy. Plans can use ... necessary, or to limit utilization of high-priced, specialty medications. UM use in oncology may have unintended consequences to patient care, such as delaying patient access to medication or increased administrative burden for the patient and provider. Prior to 2019, Medicare ...

Understanding Biologic and Biosimilar Drugs

... that they are generally larger, more complex molecules. Biologics are usually administered via injection or infusion. Most biologics in cancer care are given under the close supervision of a medical professional.  Biologics have been a part of medical treatment for a long time and have ... one, some, or all of the conditions of the reference product. While the safety of a biosimilar is assured through FDA review and approval, your health care provider should review the product label for any prescribed biosimilar.  Why biosimilars were introduced Biosimilars were introduced ... to you by your healthcare provider. This might be for several reasons, including that the biosimilar is the preferred product of your doctor or health plan. This preference might also come from physician’s experience with the product, a desire by your health plan to control costs, or ...

National Screening Survey

... say they aren’t sure and don’t regularly have a provider who lets them know when it’s time for a screening. Those with employer-provided health plans and Medicare enrollees are significantly more likely to say they know what their recommended screenings are and when to get them (69% ... annually compared to 55% of those in households earning less than $55k per year). Ninety-four percent of respondents report having a primary care doctor, and 93% say they typically see a primary care doctor at least once per year. Ninety-one percent have seen a primary care doctor within ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in ...

Choice in Treatment Modality Overwhelmingly Important to Cancer Patients & Survivors

... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy